I grew up and began my career in Brazil, where access to health care and education—especially in low-resource settings—was ...

A new pulmonary rehabilitation program at Texas Health Harris Methodist Hospital Stephenville is transforming chronic ...

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, ...

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

ABSTRACT Objective: To assess COPD Assessment Test (CAT) scores in adults with and without COPD, as well as to compare the CAT scores for nonsmokers, former smokers, and smokers without COPD with ...

PHILADELPHIA — With the 2025 GOLD report newly featuring a section dedicated to pulmonary hypertension, it is important that clinicians expand their knowledge of this comorbidity, according to a ...

The ratios of observed-to-expected deaths among patients in this age range were “substantially greater than 1” Oudah said, with patients aged 75-79 years at highest risk for PE-related death ...

Improving COPD patients’ lives needs better diagnosis, drugs, devices Chronic obstructive pulmonary disease is one of the world’s leading causes of death – more than 300 million live with ...

HealthDay News — Among patients hospitalized with a diagnosis of chronic obstructive pulmonary disorder (COPD), two-thirds of inhalers assessed at admission are misused, according to a study ...

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug — dupilumab — that showed rapid and sustained improvements in patients in a pivotal Phase 3 ...

ReAlta Life Sciences, Inc. today announced enrollment of the first patient in a Phase 2 clinical trial evaluating the safety and efficacy of RLS-0071, an investigational new drug based on ReAlta’s ...